Why read
This article is worth reading because it spotlights an emerging medtech startup revolutionizing knee injury treatment with a innovative artificial meniscus implant that could prevent arthritis and reduce the need for invasive surgeries, providing valuable insights for anyone interested in orthopedic advancements and health tech innovation.
Tiger's soapbox
We need more preservation options for early OA knee patients between the ages of 40 and 60. These patients are underserved with only palliative care (HA injections, bracing, PT, pain killers, etc) and are miserable.
This week, I’m fired up about OrthoPreserve, a Georgia Tech-spun medtech startup that's tackling meniscus tears head-on with their Defender implant—a game-changing artificial meniscus replacement that restores knee cushioning, eases chronic pain, and stalls arthritis without the need for invasive knee replacements.
Hailing from Atlanta, Georgia, this innovative team is shaking up sports medicine and joint preservation with a minimally invasive solution for patients left hurting after meniscus surgeries, helping athletes and active folks reclaim their mobility and dodge further degeneration. If you’re dialed ...
